<DOC>
	<DOCNO>NCT01362608</DOCNO>
	<brief_summary>The purpose pivotal Phase III study support registration canakinumab indication gout China , replicate global study CACZ885H2356 &amp; CACZ885H2357 demonstrating patient frequent flare gout NSAIDs and/or colchicine contraindicate , tolerate ineffective , canakinumab 150 mg s.c. give upon acute gout flare relieve sign symptom prevents recurrence gout flare compare triamcinolone acetonide 40 mg i.m .</brief_summary>
	<brief_title>Safety &amp; Efficacy Canakinumab ( ACZ885 ) Patients With Frequent Flares Whom Nonsterodial Anti-Inflammatory Drug ( NSAIDs ) and/ Colchicine Are Contraindicated , Not Tolerated Ineffective</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Gouty</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Inclusion criterion : Meeting diagnosis criterion acute arthritis primary gout . Start acute gout flare within 5 day prior study visit 1 History â‰¥ 3 gout flare within 12 month prior study start Evidence contraindication ( absolute relative ) , intolerance , lack efficacy either NSAIDs and/or colchicine Exclusion criterion : Requirement administration antibiotic latent tuberculosis ( TB ) , e.g. , isoniazide Refractory heart failure ( Stage D ) . Unstable cardiac arrhythmia unstable symptomatic coronary ischemia Secondary gout , chemotherapy induce gout , lead induce gout transplant gout Rheumatoid arthritis , evidence/suspicion infectious/septic arthritis , acute inflammatory arthritis Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Gout</keyword>
	<keyword>Inflammatory gout</keyword>
	<keyword>acute gout</keyword>
</DOC>